Paragonix SherpaPak™ Cardiac Transport System to be Featured in Clinical Presentation at 2019 American Transplant Congress

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Paragonix Technologies, Inc. today announced that the Paragonix SherpaPak™ Cardiac Transport System (CTS), the industry’s only FDA cleared and CE marked system for donor organ heart transport and storage, will be featured in a clinical presentation at the 2019 American Transplant Congress. The meeting is being held June 1-5, 2019 in Boston.

Dr. Julia Dumfarth, PhD, Chief of Heart Transplantation, Department of Cardiac Surgery, at the Medical University Innsbruck (Innsbruck, Austria) will present, “First Experience for Cold Storage of Donor Hearts with Paragonix SherpaPak.”

  • Sunday, June 2, 2019, Poster Session B: Heart and VADs: All Topics
  • Session Time: 6:00-7:00pm
  • Presentation Time: 6:00-7:00pm
  • Location: Hall C & D

Preservation of donor organs is a crucial component for the maintenance of viability during the journey from donor to recipient patient. The current standard for transporting a donor organ includes the storage in preservation solution within sequential plastic bags that are placed in a cooler containing ice. A potential issue associated with this method of storage is a too low temperature leading to tissue injury. Paragonix has developed an organ preservation system that keeps organs at a stable temperature. Dr. Dumfarth will provide an overview of a clinical case in which the Paragonix SherpaPak™ CTS was applied safely and easily, preventing the donor organ from cold injury.

“The number of clinical reports on how Paragonix SherpaPak™ CTS is transforming donor heart preservation is rapidly increasing and we are delighted about the positive impact Paragonix SherpaPak™ CTS has made for donor heart recovery teams, implanting surgeons and patients,” said Bill Edelman, Chairman and CEO of Paragonix Technologies.

Paragonix will be at booth #822, providing hands-on demonstrations of the Paragonix SherpaPak™ CTS.

The Paragonix SherpaPak™ CTS has been used by heart transplant centers in both the United States and Europe. The device is currently marketed in the United States, United Kingdom, France, Spain, Italy, Germany, Austria, Sweden and Slovak Republic in Europe.

About the American Transplant Congress
The American Transplant Congress is the Joint Annual Meeting of the American Society of Transplant Surgeons (ASTS) and the American Society of Transplantation (AST). ATC provides a forum for exchange of new scientific and clinical information relevant to solid organ and tissue transplantation and brings together transplant physicians, scientists, nurses, organ procurement personnel, pharmacists, allied health professionals and other transplant professionals. The educational offerings provide attendees the opportunity to learn cutting-edge advances in research and exchange of ideas and practice in the field of solid organ and tissue transplantation.

About the University of Innsbruck
The University of Innsbruck is a public university in Innsbruck, the capital of the Austrian federal state of Tyrol, founded in 1669. It is currently the largest education facility in the Austrian Bundesland of Tirol, the third largest in Austria behind Vienna University and the University of Graz and according to The Times Higher Education Supplement World Ranking 2010 Austria’s leading university. Significant contributions have been made in many branches, most of all in the physics department. Further, regarding the number of Web of Science-listed publications, it occupies the third rank worldwide in the area of mountain research.

About the Paragonix SherpaPak™ Cardiac Transport System
The Paragonix SherpaPak™ Cardiac Transport System (CTS) safeguards hearts during the journey from donor to recipient patient. Our device incorporates clinically proven and medically trusted cold preservation techniques in a novel suspension system to provide unprecedented physical and thermal protection. Paragonix SherpaPak™ CTS is the only commercially available FDA cleared and CE marked medical device for heart transportation.

About Paragonix Technologies, Inc.
Paragonix Technologies markets organ transportation devices that safeguard organs during the journey between donor and recipient patients. Our devices incorporate clinically proven and medically trusted cold preservation techniques in a novel suspension system to provide unprecedented physical and thermal protection. Paragonix SherpaPak™ CTS is the only commercially available FDA cleared and CE marked transport device for heart transportation. Paragonix is also developing transport devices for the lung and kidneys designed to improve donor organ quality and extending donor organ transport time.

Paragonix Technologies, Inc
245 First Street, 18th Floor
Cambridge, Massachusetts 02142
info@paragonixtechnologies.com